Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event.

TitlePancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event.
Publication TypeJournal Article
Year of Publication2014
AuthorsGandhi MD, Evens AM, Fenske TS, Hamlin P, Coiffier B, Engert A, Moskowitz AJ, Ghosh N, Petrich AM, Lomasney J, Chadburn A, Wood GS, Salva K, Nardone B, Trifilio SM, Raisch DW, West DP, Gordon LI, Winter JN
JournalBlood
Volume123
Issue18
Pagination2895-7
Date Published2014 May 01
ISSN1528-0020
KeywordsAdult, Aged, Antineoplastic Agents, Autopsy, Brentuximab Vedotin, Fatal Outcome, Female, Hodgkin Disease, Humans, Immunoconjugates, Lymphoma, Large-Cell, Anaplastic, Male, Middle Aged, Pancreatitis, Treatment Outcome, Young Adult
DOI10.1182/blood-2014-03-561878
Alternate JournalBlood
PubMed ID24786458
PubMed Central IDPMC4007615
Grant ListP30 CA014520 / CA / NCI NIH HHS / United States
5R01 CA 102713-04 / CA / NCI NIH HHS / United States
5R01 CA 125077-03 / CA / NCI NIH HHS / United States
T32AR055893 / AR / NIAMS NIH HHS / United States
Related Faculty: 
Amy Chadburn, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700